Literature DB >> 30025210

Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?

Elsa Bodier-Montagutelli1,2,3, Alexie Mayor1,2,4, Laurent Vecellio1,2, Renaud Respaud1,2,3, Nathalie Heuzé-Vourc'h1,2.   

Abstract

Keywords:  Inhalation; aerosol therapy; formulation; nebulizers; protein therapeutics

Year:  2018        PMID： 30025210     DOI： 10.1080/17425247.2018.1503251

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN： 1742-5247            Impact factor:   6.648


× No keyword cloud information.
  28 in total

Review 1.  Inhaled antibiotics during mechanical ventilation-why it will work.

Authors:  Maxime Desgrouas; Stephan Ehrmann
Journal:  Ann Transl Med       Date:  2021-04

Review 2.  Harnessing the Potential of Enzymes as Inhaled Therapeutics in Respiratory Tract Diseases: A Review of the Literature.

Authors:  Gilles Vanderstocken; Nicholas L Woolf; Giuseppe Trigiante; Jessica Jackson; Rory McGoldrick
Journal:  Biomedicines       Date:  2022-06-17

Review 3.  Monoclonal antibody therapies against SARS-CoV-2.

Authors:  Daniele Focosi; Scott McConnell; Arturo Casadevall; Emiliano Cappello; Giulia Valdiserra; Marco Tuccori
Journal:  Lancet Infect Dis       Date:  2022-07-05       Impact factor: 71.421

Review 4.  Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!

Authors:  Thomas Sécher; Alexie Mayor; Nathalie Heuzé-Vourc'h
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

5.  Exploration of Synergistic Action of Cell Wall-Degrading Enzymes against Mycobacterium tuberculosis.

Authors:  Loes van Schie; Katlyn Borgers; Gitte Michielsen; Evelyn Plets; Marnik Vuylsteke; Petra Tiels; Nele Festjens; Nico Callewaert
Journal:  Antimicrob Agents Chemother       Date:  2021-07-19       Impact factor: 5.191

Review 6.  Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.

Authors:  Claire S Whyte; Gael B Morrow; Joanne L Mitchell; Pratima Chowdary; Nicola J Mutch
Journal:  J Thromb Haemost       Date:  2020-06-03       Impact factor: 16.036

Review 7.  Inhalation delivery technology for genome-editing of respiratory diseases.

Authors:  Michael Y T Chow; Rachel Yoon Kyung Chang; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2020-06-05       Impact factor: 15.470

8.  Pharmacokinetic Analysis of Epithelial/Endothelial Cell Barriers in Microfluidic Bilayer Devices with an Air-Liquid Interface.

Authors:  Timothy S Frost; Linan Jiang; Yitshak Zohar
Journal:  Micromachines (Basel)       Date:  2020-05-25       Impact factor: 2.891

9.  Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2.

Authors:  Yanxiao Han; Petr Král
Journal:  ACS Nano       Date:  2020-04-16       Impact factor: 15.881

Review 10.  Recent progress in drug delivery.

Authors:  Chong Li; Jiancheng Wang; Yiguang Wang; Huile Gao; Gang Wei; Yongzhuo Huang; Haijun Yu; Yong Gan; Yongjun Wang; Lin Mei; Huabing Chen; Haiyan Hu; Zhiping Zhang; Yiguang Jin
Journal:  Acta Pharm Sin B       Date:  2019-08-19       Impact factor: 11.413
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.